Author:
Northridge Jennifer L.,Maslyanskaya Sofya
Publisher
Springer International Publishing
Reference31 articles.
1. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR. 2016;65(RR-04):1–66.
10.15585/mmwr.rr6504a1
.
2. Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR. 2016;65(RR-03):1–104.
10.15585/mmwr.rr6503a1
.
3. Centers for Disease Control and Prevention. Summary chart of U.S. medical eligibility criteria for contraceptive use. 2016. Available via CDC.
http://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf
. Accessed 29 July 2016.
4. Trenor CC, Chung RJ, Michelson AD, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347–57.
https://doi.org/10.1542/peds.2010-2221
.
5. Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123(7):612–24.
https://doi.org/10.1016/j.amjmed.2009.12.021
.